Active chronic hepatitis after chlorpromazine ingestion.
نویسندگان
چکیده
منابع مشابه
Chronic Active Hepatitis
Our previous observations of highly significant increases in high titre antibodies to measles and rubella in patients with chronic active hepatitis have been extended and it has been shown that these reactions do not occur in other forms of liver disease. Significant increases in antibody titres to cytomegalovirus have also been found in patients with chronic active hepatitis (p<0001) and alcoh...
متن کاملSarcoidosis after interferon therapy for chronic active hepatitis C.
Sarcoidosis is characterized by multisystemic granulomatous lesions of unknown etiology. A 62-year-old woman developed sarcoidosis after treatment with alpha-2a interferon (IFN) for 24 weeks (total dose: 522 million units) for chronic hepatitis C. She developed complete atrioventricular block and multiple noncaseating granulomatous lesions in the lung. IFN therapy, which may disturb cellular im...
متن کاملInvolvement in Chronic Active Hepatitis
Rabbit liver plasma membranes were isolated and purified by using an aqueous twophase polymer system. Examination of these preparations with respect to electronmicroscopical appearance, distribution of marker enzymes and gross biochemical composition revealed them to be free from contamination by intracellular components. Sera from ten patients with chronic active hepatitis, four with and six w...
متن کاملActive chronic hepatitis. Part I.
IN 1950 Waldenstrom first drew attention to the occurrence of a form of chronic liver disease in young people, predominantly adolescent girls, in whom there was moderate jaundice, enlargement of the liver and spleen, acne, amenorrhoea and hyperglobulinaemia. The occurrence of fever, arthralgia and Cushingoid features was noted (Kunkel et al 1951, Beam et al 1956), the LE cell phenomenon was rep...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1973
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.1.5854.655